ABCA4 rs121908002: Understanding This Stargardt Disease Variant
The rs121908002 variant is a specific genetic change located within the ABCA4 gene. It is recognized as a pathogenic missense variant associated with autosomal recessive Stargardt disease and related cone-rod dystrophy conditions.
What each genotype means
Typical ABCA4 genotype
This genotype represents the common, non-variant sequence at this position in the ABCA4 gene. It is not associated with the pathogenic effects linked to Stargardt disease or cone-rod dystrophy at this specific site.
This is the most common genotype found in the general population.
Carrier of pathogenic variant
This genotype indicates you carry one copy of a known pathogenic variant in the ABCA4 gene. Because Stargardt disease is typically inherited in an autosomal recessive pattern, carrying a single copy is generally not sufficient to cause the condition, though you should consult with a genetic counselor regarding family planning.
The minor allele is found in approximately 0.1% to 0.5% of individuals in European populations.
Potential disease-associated genotype
This genotype indicates you carry two copies of this pathogenic variant. This is associated with an increased risk for autosomal recessive Stargardt disease or cone-rod dystrophy, which are conditions affecting retinal function. Please discuss these results with an ophthalmologist or a clinical geneticist to understand your specific health context.
This genotype is extremely rare in the general population.
What is the rs121908002 Variant?
The rs121908002 variant is a specific alteration in the DNA sequence of the ABCA4 gene. In genetics, a variant like this is often classified as a missense mutation, meaning it results in a change to the amino acid sequence of the protein the gene encodes. This specific variant is well-characterized in clinical databases as being pathogenic, which means it is known to disrupt the normal function of the protein. Because it is located within the ABCA4 gene, it is primarily studied in the context of inherited retinal disorders. Geneticists track this variant to understand how it contributes to the development of conditions that affect the macula, the part of the eye responsible for sharp, central vision. It is important to note that the presence of this variant alone does not guarantee the development of a condition, as the inheritance pattern for these associated diseases is typically autosomal recessive.
The Role of the ABCA4 Gene
The ABCA4 gene provides instructions for making a protein called the ATP-binding cassette transporter, sub-family A, member 4. This protein is found in the photoreceptor cells of the retina, specifically in the disc membranes of rod and cone cells. Its primary job is to transport a substance called all-trans-retinal out of these cells after it has been used in the visual cycle. When the ABCA4 protein is not functioning correctly, all-trans-retinal can accumulate and form toxic byproducts known as bisretinoids. These substances eventually build up as lipofuscin in the retinal pigment epithelium, a layer of cells that supports the photoreceptors. Over time, this accumulation can lead to oxidative stress and the death of these vital cells, which is the underlying mechanism for the vision loss observed in conditions like Stargardt disease and cone-rod dystrophy.
Research and Clinical Associations
Research has firmly established that variants in the ABCA4 gene are a leading cause of inherited retinal dystrophies. The rs121908002 variant is specifically linked to autosomal recessive Stargardt disease, a condition characterized by progressive central vision loss that often begins in childhood or adolescence. Because the condition is autosomal recessive, an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to manifest the clinical symptoms. In some cases, individuals may carry only one copy, making them carriers who generally do not show symptoms. The evidence for the pathogenicity of this variant is strong, supported by clinical observations and molecular studies. However, the clinical expression can be highly variable, and researchers continue to study how other genetic modifiers or environmental factors might influence the severity and progression of the disease in different individuals.
Population Frequency and Distribution
The frequency of the rs121908002 variant varies across different human populations. Current data indicates that the minor allele frequency for this variant is approximately 0.001 to 0.005 in European populations. This relatively low frequency suggests that it is not a common variant in the general population. Because ABCA4-related diseases are rare, the occurrence of this specific variant is often studied within families or cohorts of patients already diagnosed with retinal dystrophies. It is important to recognize that population frequencies are based on large-scale genomic databases and may not reflect the specific risk for any single individual. Genetic diversity means that the prevalence of such variants can differ significantly between ethnic groups, and ongoing research continues to refine these estimates as more genomic data becomes available from diverse global populations.
What This Information Means for You
If you have received information about your status regarding the rs121908002 variant, it is essential to understand that this is a complex genetic finding. This variant is associated with serious, inherited retinal conditions, but it is not a diagnostic tool on its own. Genetic testing results should always be interpreted by a qualified healthcare professional, such as a genetic counselor or an ophthalmologist specializing in retinal diseases. They can help place this information in the context of your personal and family medical history. You cannot use this information to self-diagnose or predict the exact course of any potential condition. If you are concerned about your vision or your genetic risk, please consult with a medical professional who can provide appropriate clinical evaluation, testing, and guidance tailored to your specific health needs.
How common is this variant?
The rs121908002 variant is rare, with a minor allele frequency estimated between 0.001 and 0.005 in European populations.
Frequently asked questions
What is Stargardt disease?
Stargardt disease is an inherited retinal disorder that causes progressive loss of central vision. It is typically caused by mutations in the ABCA4 gene that lead to the accumulation of toxic byproducts in the eye.
Is rs121908002 a cause of blindness?
The variant is associated with retinal dystrophy, which can lead to significant vision impairment. However, the severity and progression of vision loss vary greatly between individuals.
Should I get tested for this variant?
Genetic testing is usually recommended if you have a family history of retinal disease or are experiencing symptoms of vision loss. You should discuss the necessity and implications of testing with a genetic counselor or eye specialist.
Can I prevent Stargardt disease if I have this variant?
Currently, there is no known way to prevent the onset of Stargardt disease if you carry the necessary pathogenic variants. Research into gene therapies and other treatments is ongoing, and you should consult a specialist for the latest clinical information.
Sources & further reading
Educational information only, last refreshed 10/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908002?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ABCA4
This variant is associated with Stargardt disease and other retinal dystrophies.
This SNP is involved in the retinal phototransduction cycle and linked to Stargardt disease and age-related macular degeneration predisposition.
Genomic variant within the ATP-binding cassette retinal transporter ABCA4 locus implicated in retinal degenerations and macular disease.
Known as the Gly1961Glu (G1961E) variant in ABCA4, a prevalent hypomorphic mutation contributing to late-onset Stargardt disease and cone-rod dystrophy.
This variant is associated with carrier status for Stargardt disease, an inherited retinal disorder.
A well-documented pathogenic missense change in ABCA4 causing autosomal recessive Stargardt disease and cone-rod dystrophy.